The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Methylene blue and Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508575102 · Cited by 734
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
Praticò, D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.001 · Cited by 606
Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds
Hassan, H. M., & Fridovich, I. (1979) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(79)90289-3 · Cited by 596
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.
Wischik, C. M., Edwards, P. C., Lai, R. Y., Roth, M., & Harrington, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11213 · Cited by 547
Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins
Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S.-I., Iwatsubo, T., Goedert, M., & Hasegawa, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408714200 · Cited by 540
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Radic, Z., Pickering, N. A., Vellom, D. C., Camp, S., & Taylor, P. (1993) · Biochemistry · doi:10.1021/bi00096a018 · Cited by 437
Methylene Blue - a Therapeutic Dye for All Seasons?
Wainwright, M., & Crossley, K. B. (2002) · Journal of Chemotherapy · doi:10.1179/joc.2002.14.5.431 · Cited by 396
Pharmacokinetics and organ distribution of intravenous and oral methylene blue
Peter, C., Hongwan, D., Küpfer, A., & Lauterburg, B. H. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000124 · Cited by 373
Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease
Giacobini, E. (2003) · Neurochemical Research · doi:10.1023/a:1022869222652 · Cited by 371
Clifton, J., & Leikin, J. B. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200307000-00009 · Cited by 318
Ramsay, R. R., Dunford, C., & Gillman, P. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707430 · Cited by 276
Methylene Blue Delays Cellular Senescence and Enhances Key Mitochondrial Biochemical Pathways
Atamna, H., Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H., & Ames, B. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9610com · Cited by 272
Amyloid–cholinesterase interactions: Implications for Alzheimer’s disease
Inestrosa, N. C., Dinamarca, M. C., & Alvarez, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06238.x · Cited by 261
Methylene blue as an inhibitor of superoxide generation by xanthine oxidase
Salaris, S. C., Babbs, C. F., & Voorhees, W. D. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90311-r · Cited by 223
Targeting acetylcholinesterase to treat neurodegeneration
Holzgrabe, U., Kapková, P., Alptüzün, V., Scheiber, J., & Kugelmann, E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.161 · Cited by 217
Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., & Glabe, C. G. (2007) · Biochemistry · doi:10.1021/bi700411k · Cited by 213
Adverse Effects of Methylene Blue on the Central Nervous System
Vutskits, L., Briner, A., Klauser, P., Gascon, E., Dayer, A. G., Kiss, J. Z., Muller, D., Licker, M. J., & Morel, D. R. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181684be4 · Cited by 187
Entry of Oximes into the Brain: A Review
Lorke, D., Kalasz, H., Petroianu, G., & Tekes, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783955563 · Cited by 184
Self-citationProphylaxis and reversal of ifosfamide encephalopathy with methylene-blue
Küpfer, A., Aeschlimann, C., Wermuth, B., & Cerny, T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91839-2 · Cited by 178
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
Wegener, G., Volke, V., & Rosenberg, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703349 · Cited by 167
Buchholz, K., Schirmer, R. H., Eubel, J. K., Akoachere, M. B., Dandekar, T., Becker, K., & Gromer, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00773-07 · Cited by 163
DiSanto, A. R., & Wagner, J. G. (1972) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600610710 · Cited by 145
Mechanisms Behind the Neuroprotective Actions of Cholinesterase Inhibitors in Alzheimer Disease
Nordberg, A. K. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213804.59187.2d · Cited by 137
Therapeutic Strategies for Alzheimer’s Disease
Barten, D. M., & Albright, C. F. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8031-2 · Cited by 132
Factors Affecting Virus Photoinactivation by a Series of Phenothiazine Dyes
Wagner, S. J., Skripchenko, A., Robinette, D., Foley, J. W., & Cincotta, L. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb05208.x · Cited by 132
Hope in Alzheimer's fight emerges from unexpected places
Gura, T. (2008) · Nature Medicine · doi:10.1038/nm0908-894 · Cited by 123
Methylene blue improves brain oxidative metabolism and memory retention in rats
Callaway, N. L., Riha, P. D., Bruchey, A. K., Munshi, Z., & Gonzalez-Lima, F. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.007 · Cited by 122
Methylene blue prevents neurodegeneration caused by rotenone in the retina
Zhang, X., Rojas, J. C., & Gonzalez-Lima, F. (2006) · Neurotoxicity Research · doi:10.1007/bf03033307 · Cited by 118
Wischik, C. M., Bentham, P., Wischik, D., & Seng, K. M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.438 · Cited by 118
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients
Lorke, D. E., Lü, G., Cho, E. Y. P., & Yew, D. T. W. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-36 · Cited by 117
Self-citationDeiana, S., Harrington, C. R., Wischik, C. M., & Riedel, G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1394-2 · Cited by 108
Stimulation of respiration by methylene blue in rat liver mitochondria
Visarius, T. M., Stucki, J. W., & Lauterburg, B. H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00767-9 · Cited by 104
Extinction Memory Improvement by the Metabolic Enhancer Methylene BluePreprint
Gonzalez-Lima, F., & Bruchey, A. K. (2004) · Learning & Memory · doi:10.1101/lm.82404 · Cited by 102
The use of dyes in modern biomedicine
Wainwright, M. (2003) · Biotechnic & Histochemistry · doi:10.1080/10520290310001602404 · Cited by 100
Naylor, G. J., Martin, B., Hopwood, S. E., & Watson, Y. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90265-9 · Cited by 96
Riha, P. D., Bruchey, A. K., Echevarria, D. J., & Gonzalez-Lima, F. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.001 · Cited by 92
Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease
Geula, C., & Darvesh, S. (2004) · Drugs of today · doi:10.1358/dot.2004.40.8.850473 · Cited by 88
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria
Rengelshausen, J., Burhenne, J., Fr�hlich, M., Tayrouz, Y., Singh, S. K., Riedel, K., M�ller, O., Hoppe‐Tichy, T., Haefeli, W. E., Mikus, G., et al. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0818-0 · Cited by 84
Aeschlimann, C., Cerny, T., & Kupfer, A. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08471-5 · Cited by 71
Potential of Methylene Blue to Block Oxygen Radical Generation in Reperfusion Injury
Kelner, M. J., Bagnell, R. D., Hale, B., & Alexander, N. M. (1988) · Springer eBooks · doi:10.1007/978-1-4684-5568-7_146 · Cited by 63
Deutsch, S. I., Rosse, R. B., Paul, S. M., Tomasino, V., Koetzner, L., Morn, C. B., & Mastropaolo, J. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00153-5 · Cited by 63
The interaction between methylene blue and the cholinergic system
Pfaffendorf, M., Bruning, T. A., Batink, H. D., & van Zwieten, P. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701355 · Cited by 62
Narsapur (1983) · doi:10.1016/0165-0327(83)90008-3 · Cited by 59
Darvesh, S., McDonald, R. S., Penwell, A., Conrad, S., Darvesh, K. V., Mataija, D., Gomez, G., Caines, A., Walsh, R., & Martin, E. V. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.059 · Cited by 59
Methylene-Blue–Associated Encephalopathy
Sweet, G., & Standiford, S. B. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.12.030 · Cited by 59
The brain metabolic enhancer methylene blue improves discrimination learning in rats
Wrubel, K. M., Riha, P. D., Maldonado, M. A., McCollum, D., & Gonzalez-Lima, F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.02.018 · Cited by 58
Darvesh, S., McDonald, R. S., Darvesh, K. V., Mataija, D., Conrad, S., Gomez, G., Walsh, R., & Martin, E. V. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.06.060 · Cited by 53
Hattori, M., Sugino, E., Minoura, K., In, Y., Sumida, M., Taniguchi, T., Tomoo, K., & Ishida, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.001 · Cited by 53
Neurosyphilis, Malaria, and the Discovery of Antipsychotic Agents
Frankenburg, F. R., & Baldessarini, R. J. (2008) · Harvard Review of Psychiatry · doi:10.1080/10673220802432350 · Cited by 52
Methylene Blue by Intraosseous Infusion for Methemoglobinemia
Herman, M. I., Chyka, P. A., Butler, A. Y., & Rieger, S. E. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70427-0 · Cited by 51
Methylene blue alters retention of inhibitory avoidance responses
Martinez, J. L., Jensen, R. A., Vásquez, B. J., McGuinness, T. L., & McGaugh, J. L. (1978) · Physiological Psychology · doi:10.3758/bf03326744 · Cited by 50
Kristiansen, J. E. (1989) · PubMed · Cited by 45
Phencyclidine‐Induced Behaviour in Mice Prevented by Methylene Blue
Klamer, D., Engel, J. A., & Svensson, L. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto940203.x · Cited by 36
Inactivation of the Scrapie Agent by Ultraviolet Irradiation in the Presence of Chlorpromazine
Dees, C., Wade, W. F., German, T. L., & Marsh, R. F. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-4-845 · Cited by 32
Naylor, G. J., Smith, A. H. W., & Connelly, P. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90229-6 · Cited by 31
Methylene blue is a potent monoamine oxidase inhibitor
Gillman, P. K., Ng, B., Cameron, A. J. D., et al. (2008) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03017212 · Cited by 30
Yücel, Y. Y., Tacal, Ö., & Özer, İ. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.07.006 · Cited by 25
Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue
Khavandi, A., Whitaker, J., & Gonna, H. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02168.x · Cited by 21
Müller, T. (1998) · PubMed · doi:10.14670/hh-13.1019 · Cited by 18
Cited by
Cellular and molecular actions of Methylene Blue in the nervous system
Oz, M., Lorke, D. E., Hasan, M., & Petroianu, G. A. (2011) · Medicinal Research Reviews · doi:10.1002/med.20177 · Cited by 443
Self-citation“Lest we forget you — methylene blue …”
Schirmer, R. H., Adler, H., Pickhardt, M., & Mandelkow, E. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.012 · Cited by 414
The Revitalized Tau Hypothesis on Alzheimer's Disease
Maccioni, R. B., Farías, G., Morales, I., & Navarrete, L. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.03.007 · Cited by 312
Salomone, S., Caraci, F., Leggio, G. M., Fedotova, J., & Drago, F. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04134.x · Cited by 309
Saha, J., Begum, A., Mukherjee, A., & Kumar, S. (2017) · Sustainable Environment Research · doi:10.1016/j.serj.2017.04.003 · Cited by 308
Metadata
- Authors
- Oz, M., Lorke, D. E., & Petroianu, G. A.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 78
- Issue
- 8
- Pages
- 927-932
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2015389516
- Cited by
- 257
- References
- 63
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.